Literature DB >> 22450509

Neuromuscular disease: Muscular dystrophy--something new on God's green earth?

Alessandra Ferlini.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22450509     DOI： 10.1038/nrneurol.2012.41

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  10 in total

1.  Newborn and childhood screening programmes: criteria, evidence, and current policy.

Authors:  D A C Elliman; C Dezateux; H E Bedford
Journal:  Arch Dis Child       Date:  2002-07       Impact factor: 3.791

2.  Newborn screening for Duchenne muscular dystrophy.

Authors:  E P Parsons; D M Bradley; A J Clarke
Journal:  Arch Dis Child       Date:  2003-01       Impact factor: 3.791

Review 3.  Ethical aspects of the expansion of neonatal screening programme due to technological advances.

Authors:  David Elliman
Journal:  Clin Chem Lab Med       Date:  2012-06       Impact factor: 3.694

Review 4.  New technologies extend the scope of newborn blood-spot screening, but old problems remain unresolved.

Authors:  Rodney J Pollitt
Journal:  Acta Paediatr       Date:  2010-12       Impact factor: 2.299

Review 5.  Duchenne muscular dystrophy: issues in expanding newborn screening.

Authors:  Alex R Kemper; Melissa A Wake
Journal:  Curr Opin Pediatr       Date:  2007-12       Impact factor: 2.856

6.  Screening newborn infants for Duchenne muscular dystrophy.

Authors:  J E Bowman
Journal:  BMJ       Date:  1993-02-06

Review 7.  Change in natural history of Duchenne muscular dystrophy with long-term corticosteroid treatment: implications for management.

Authors:  Richard T Moxley; Shree Pandya; Emma Ciafaloni; Deborah J Fox; Kim Campbell
Journal:  J Child Neurol       Date:  2010-06-25       Impact factor: 1.987

8.  Evidence-based path to newborn screening for Duchenne muscular dystrophy.

Authors:  Jerry R Mendell; Chris Shilling; Nancy D Leslie; Kevin M Flanigan; Roula al-Dahhak; Julie Gastier-Foster; Kelley Kneile; Diane M Dunn; Brett Duval; Alexander Aoyagi; Cindy Hamil; Maha Mahmoud; Kandice Roush; Lauren Bird; Chelsea Rankin; Heather Lilly; Natalie Street; Ram Chandrasekar; Robert B Weiss
Journal:  Ann Neurol       Date:  2012-03       Impact factor: 10.422

9.  Care for patients with ultra-rare disorders.

Authors:  Raoul C M Hennekam
Journal:  Eur J Med Genet       Date:  2010-12-10       Impact factor: 2.708

10.  Parental attitudes regarding newborn screening of PKU and DMD.

Authors:  Elizabeth Campbell; Lainie Friedman Ross
Journal:  Am J Med Genet A       Date:  2003-07-15       Impact factor: 2.802
  10 in total
  1 in total

1.  Guidance in social and ethical issues related to clinical, diagnostic care and novel therapies for hereditary neuromuscular rare diseases: "translating" the translational.

Authors:  Pauline McCormack; Simon Woods; Annemieke Aartsma-Rus; Lynn Hagger; Agnes Herczegfalvi; Emma Heslop; Joseph Irwin; Janbernd Kirschner; Patrick Moeschen; Francesco Muntoni; Marie-Christine Ouillade; Jes Rahbek; Christoph Rehmann-Sutter; Francoise Rouault; Thomas Sejersen; Elizabeth Vroom; Volker Straub; Kate Bushby; Alessandra Ferlini
Journal:  PLoS Curr       Date:  2013-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.